Canopus BioPharma Incorporated
CBIA · OTC
8/31/2022 | 8/31/2021 | 6/30/2014 | 6/30/2013 | |
|---|---|---|---|---|
| Market Cap | $11 | $4 | $10 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $2 | $4 |
| Enterprise Value | $11 | $4 | $12 | $5 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$1 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| Net Income | -$1 | -$0 | -$1 | -$1 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.007 | 0 | -0.021 | -0.025 |
| % Growth | – | 100% | 16.1% | – |
| Operating Cash Flow | -$0 | -$0 | $2 | -$1 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$0 | -$0 | $2 | -$1 |